The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formation

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Hovden A-O, Sommerfelt MA. The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formation. APMIS 2002;110:697–708.

CD4 is the principal binding site for human and simian immunodeficiency virus (HIV/SIV) receptor interactions and the α chemokine receptor CXCR4 has been implicated as a primordial lentivirus receptor. This study sought to determine the relevance of CD4 and CXCR4 in virus-receptor interactions for the prototype lentivirus, maedi-visna virus (MVV) of sheep. Neither CD4 nor α/β chemokine receptors represent principal receptors for MVV since human osteosarcoma cells devoid of these molecules were susceptible to productive infection. Interestingly, the presence of either CD4 and/or CXCR4 on indicator cells dramatically enhanced MVV-induced cell fusion (syncytium formation) for three independent virus strains. Syncytium formation results from virus-receptor interactions and can be inhibited by receptor ligands. However, neither SDF-1α that binds CXCR4 nor recombinant gp120 (rgp120) that binds CD4 could specifically inhibit the observed enhancement of MVV-induced cell fusion under conditions that significantly reduced HIV-1-induced cell fusion. Our observations suggest that CD4 and CXCR4 may represent optional auxiliary components of an MVV receptor (or receptor complex) that facilitate MVV-mediated membrane fusion events, a feature important for virus entry. This potential accessory role for CXCR4 in MVV receptor interactions may reflect the distant relationship between the ovine (MVV) and the human/feline lentiviruses (HIV/FIV).

Keywords: CD4; CXCR4; Syncytia; maedi-visna virus

Document Type: Research Article

DOI: http://dx.doi.org/10.1034/j.1600-0463.2002.1101003.x

Affiliations: Department of Molecular Biology and

Publication date: October 1, 2002

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more